Recovery & Repair

KPV Dosing & Reconstitution Calculator

Anti-inflammatory tripeptide derived from alpha-MSH supporting gut and skin health.

TL;DR - KPV is a recovery & repair peptide with a typical starting dose of 500 µg. For a 10 mg vial, add 2 mL bacteriostatic water to yield 5000 µg/mL.
500 µg
Start Dose
10 mg
Vial
2 mL
BAC Water
5000
µg/mL
500 µg draw on a 100-unit insulin syringe
010203040506070809010010 IUascendpeptide.org
Compare Similar
This Peptide
KPV
500 µg start
BPC-157
500 µg start
Coming soon
TB-500
2.5 mg start
Coming soon
Track KPV in Protocol Tracker
Frequently Asked
How do I reconstitute KPV?
Add 2 mL of bacteriostatic water to a 10 mg vial, injecting slowly down the inside wall. Swirl gently; never shake. This yields a concentration of 5000 µg/mL.
What is the recommended dose of KPV?
A typical research dose is 500 µg. Consult the ASCEND calculator for your specific vial concentration and draw volume.
How many doses are in a KPV vial?
A 10 mg vial reconstituted with 2 mL BAC water yields approximately 20 doses at 500 µg each.
How many IU is 500 µg of KPV on a syringe?
With a 10 mg vial reconstituted in 2 mL bacteriostatic water, the concentration is 5000 µg/mL. For a 500 µg dose: Volume = 500 µg ÷ 5000 µg/mL = 0.1 mL. Draw to the 10 line on a 100-unit insulin syringe. You can adjust these values in the ASCEND calculator for any vial size.
What does a KPV dosage calculator do?
A KPV dosage calculator converts your vial size and BAC water volume into an exact syringe draw in IU. Enter your vial strength (10 mg), reconstitution volume (2 mL), and target dose to get the precise line to draw on an insulin syringe.
What is the KPV reconstitution calculator formula?
Draw volume (mL) = Dose (µg) divided by Concentration (µg/mL). For a 10 mg vial with 2 mL BAC water: concentration = 5000 µg/mL. For a 500 µg dose, the ASCEND calculator gives the exact IU line on your syringe instantly.
Peptide Intelligence
What is the mechanism of KPV?
KPV (Lys-Pro-Val) is a C-terminal fragment of alpha-MSH that acts on melanocortin receptors (MC1R, MC3R) to suppress NF-kB signaling and reduce pro-inflammatory cytokine production. It is particularly active in gut epithelium and skin inflammatory models.
What conditions is KPV being researched for?
Primary research applications include inflammatory bowel disease, colitis, wound healing, and skin inflammatory conditions. KPV shows efficacy via both systemic injection and oral/rectal routes in rodent IBD models due to its stability in the gut environment.
What is the half-life of KPV?
KPV has a short half-life of approximately 30–60 minutes in plasma. However, its small size and resistance to some peptidases gives it surprising gut stability. Subcutaneous protocols typically use twice-daily administration.
Primary Sources
Anti-inflammatory Alpha-MSH (J Leukoc Biol 2003)
Data last reviewed 2026-06-03 · Methodology →
Cite This Calculator